S&P 500   2,995.99 (-0.36%)
DOW   26,788.10 (-0.15%)
QQQ   191.85 (-0.80%)
AAPL   239.96 (-0.23%)
FB   182.34 (-3.91%)
MSFT   136.37 (-1.49%)
GOOGL   1,241.20 (-0.25%)
AMZN   1,765.73 (-1.12%)
CGC   21.15 (+3.93%)
NVDA   195.61 (-0.20%)
MU   44.66 (-1.24%)
BABA   169.89 (-2.09%)
GE   9.06 (+3.07%)
TSLA   255.58 (+0.82%)
AMD   31.51 (-1.62%)
T   38.17 (-0.16%)
F   9.07 (+0.44%)
ACB   3.58 (-2.98%)
PRI   125.80 (+0.09%)
NFLX   266.69 (-4.09%)
BAC   31.20 (+0.58%)
GILD   65.86 (+1.00%)
DIS   132.40 (+1.64%)
S&P 500   2,995.99 (-0.36%)
DOW   26,788.10 (-0.15%)
QQQ   191.85 (-0.80%)
AAPL   239.96 (-0.23%)
FB   182.34 (-3.91%)
MSFT   136.37 (-1.49%)
GOOGL   1,241.20 (-0.25%)
AMZN   1,765.73 (-1.12%)
CGC   21.15 (+3.93%)
NVDA   195.61 (-0.20%)
MU   44.66 (-1.24%)
BABA   169.89 (-2.09%)
GE   9.06 (+3.07%)
TSLA   255.58 (+0.82%)
AMD   31.51 (-1.62%)
T   38.17 (-0.16%)
F   9.07 (+0.44%)
ACB   3.58 (-2.98%)
PRI   125.80 (+0.09%)
NFLX   266.69 (-4.09%)
BAC   31.20 (+0.58%)
GILD   65.86 (+1.00%)
DIS   132.40 (+1.64%)
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space
(ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Aytu BioscienceAddex TherapeuticsOncoSec MedicalCeaproCellectar Biosciences
SymbolNASDAQ:AYTUOTCMKTS:ADDXFNASDAQ:ONCSOTCMKTS:CRPOFNASDAQ:CLRB
Price Information
Current Price$1.16$1.91$2.47$0.29$1.51
52 Week RangeBuyN/ABuyN/ABuy
Analyst Ratings
Consensus RecommendationBuyN/ABuyN/ABuy
Consensus Price Target$7.38N/A$25.33N/A$6.67
% Upside from Price Target535.78% upsideN/A925.64% upsideN/A341.50% upside
Trade Information
Market Cap$21.05 million$29.66 million$23.83 million$23.97 million$14.60 million
Beta4.640.232.311.11.31
Average Volume463,704375169,24426,748239,473
Sales & Book Value
Annual Revenue$7.32 millionN/AN/A$8.94 millionN/A
Price / Sales2.80N/AN/A2.49N/A
CashflowN/AN/AN/AN/AN/A
Price / CashN/AN/AN/AN/AN/A
Book Value$0.43 per shareN/A$4.38 per share$0.23 per share$2.26 per share
Price / Book2.70N/AN/A1.25N/A
Profitability
Net Income$-27,130,000.00N/A$-39,130,000.00$-240,000.00$-13,240,000.00
EPS($3.48)N/AN/AN/A($4.66)
Trailing P/E RatioN/A0.000.000.00N/A
Forward P/E RatioN/AN/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net Margins-370.62%N/AN/A-8.15%N/A
Return on Equity (ROE)-204.18%N/A-149.89%-4.91%-135.68%
Return on Assets (ROA)-81.33%N/A-115.79%-4.19%-96.21%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity RatioN/AN/AN/A0.14%0.03%
Current Ratio2.87%N/A5.05%3.60%6.80%
Quick Ratio2.60%N/A5.05%3.03%6.80%
Ownership Information
Institutional Ownership Percentage18.09%N/A5.83%N/A21.29%
Insider Ownership Percentage5.80%N/A5.40%N/A4.26%
Miscellaneous
Employees521733N/A7
Shares Outstanding17.69 million15.53 million10.64 million77.34 million9.40 million
Next Earnings Date11/6/2019 (Estimated)N/A10/25/2019 (Estimated)11/20/2019 (Estimated)11/12/2019 (Estimated)
OptionableNot OptionableNot OptionableNot OptionableNot OptionableNot Optionable
 Aytu BioscienceAddex TherapeuticsOncoSec MedicalCeaproCellectar Biosciences

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel